Back to search

France· FR:61026771

CITRATE DE BETAINE CITRON UPSA 2 g SANS SUCRE, comprimé effervescent édulcoré à la saccharine sodique

A betaine product containing citrate de bétaïne anhydre, registered in France by UPSA. The same ATC class is registered in 15 of our 19 countries.

ATC A16AA06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCITRATE DE BETAINE CITRON UPSA 2 g SA…ATCA16AA06REGISTER NO.FR:61026771PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Betaine is registered in 15 of 19 countries.

Countries holding a registration under ATC A16AA06 (betaine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Betaine · ATC A16AA06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CITRATE DE BÉTAÏNE ANHYDRE
Manufacturer
UPSA
Country
France (FR)
ATC code
A16AA06
ATC class
Betaine
Defined daily dose
6 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400934965852
    tube(s) polypropylène polyéthylène de 20 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Betaine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betaine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Greece · Alkacitrat
  • Iceland · Amversio, Cystadane
  • Liechtenstein · Amversio, Cystadane
  • Norway · Amversio, Cystadane

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5aea6d10-32ac-4f67-a802-24340eb83fe1
GET /v1/drugs/5aea6d10-32ac-4f67-a802-24340eb83fe1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61026771",
  "date_amm": "1990-08-22",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CITRATE DE BÉTAÏNE ANHYDRE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé effervescent(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about betaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.